Approaches to Study CFTR Pre-mRNA Splicing Defects

Methods in Molecular Biology

Volumn 741, Issue , 2011, Pages 155-169

  Goina, Elisa ^a   Fernandez Alanis, Eugenio ^a   Pagani, Franco ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

hybrid minigenes; Pre mRNA splicing; siRNA; splicing factors; splicing regulatory elements

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; PROTEIN TDP-43; RECOMBINANT DNA; RNA PRECURSOR; SMALL INTERFERING RNA; TAR DNA BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; GENE SILENCING; GENETIC PROCEDURES; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

BASE SEQUENCE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA, RECOMBINANT; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; GENETIC TECHNIQUES; HELA CELLS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80052311946     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-117-8_11     Document Type: Chapter

References (25)

1. Cartegni, L., Chew, S. L., and Krainer, A. R. (2002) Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285–298.
2. Pagani, F., Buratti, E., Stuani, C., and Baralle, F. E. (2003) Missense, nonsense and neutral mutations define juxtaposed regulatory elements of splicing in CFTR Exon 9. J. Biol. Chem. 278, 26580–26588.
3. Pagani, F., Stuani, C., Tzetis, M., Kanavakis, E., Efthymiadou, A., Doudounakis, S. et al. (2003) New type of disease causing mutations: The example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum. Mol. Genet. 12, 1111–1120.
4. Faustino, N. A., and Cooper, T. A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419–437.
5. Pagani, F., and Baralle, F. E. (2004) Genomic variants in exons and introns: Identifying the splicing spoilers. Nat. Rev. Genet. 5, 389–396.
6. Buratti, E., Baralle, M., and Baralle, F. E. (2006) Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res. 34, 3494–3510.
7. Cooper, T. A. (2005) Use of minigene systems to dissect alternative splicing elements. Methods 37, 331–340.
8. Pagani, F., Raponi, M., and Baralle, F. E. (2005) Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc. Natl. Acad. Sci. USA 102, 6368–6372.
9. Park, J. W., and Graveley, B. R. (2005) Use of RNA interference to dissect the roles of trans-acting factors in alternative pre-mRNA splicing. Methods 37, 341–344.
10. ′ splice sites cause CFTR exon 9 to be vulnerable to skipping. Am. J. Hum. Genet. 71, 294–303.
11. Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A. J. et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regu- lator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J. Clin. Invest. 101, 487–496.
12. Chu, C. S., Trapnell, B. C., Curristin, S., Cutting, G. R., and Crystal, R. G. (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat. Genet. 3, 151–156.
13. Buratti, E., and Baralle, F. E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337–36343.
14. Buratti, E., Dörk, T., Zuccato, E., Pagani, F., Romano, M., and Baralle, F. E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774–1784.
15. Ayala, Y. M., Pagani, F., and Baralle, F. E. (2006) TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett. 580, 1339–1344.
16. D’Ambrogio, A., Buratti, E., Stuani, C., Guarnaccia, C., Romano, M., Ayala, Y. M. et al. (2009) Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 37, 4116–4126.
17. Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M. et al. (2000) Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 275, 21041–21047.
18. Niksic, M., Romano, M., Buratti, E., Pagani, F., and Baralle, F. E. (1999) Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum. Mol. Genet. 8, 2339–2349.
19. Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q., and Krainer, A. R. (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568–3571.
20. Fairbrother, W. G., Yeh, R. F., Sharp, P. A., and Burge, C. B. (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297, 1007–1013.
21. Fairbrother, W. G., Holste, D., Burge, C. B., and Sharp, P. A. (2004) Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol. 2, E268.
22. Zhang, X. H., and Chasin, L. A. (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev. 18, 1241–1250.
23. Zhang, X. H., Kangsamaksin, T., Chao, M. S., Banerjee, J. K., and Chasin, L. A. (2005) Exon inclusion is dependent on predictable exonic splicing enhancers. Mol. Cell. Biol. 25, 7323–7332.
24. Venables, J. P., Koh, C. S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L. et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol. Cell. Biol. 28, 6033–6043.
25. Goina, E., Skoko, N., and Pagani, F. (2008) Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant. Mol. Cell. Biol. 28, 3850–3860.